Fundz
Free weekly newsletter

Get the free weekly contract digest

The new new contracts, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.

Weekly Digest

New new contracts, summarized for you

Straight to Inbox

No login, no app to check — it comes to you

Contract Trends

See who's moving and how much in your market

No credit card required Weekly contract digest

NovaBay Pharmaceuticals Agrees to Sell Avenova Brand and Business to PRN Physician Recommended Nutriceuticals

Sep 20, 2024•over 1 year ago

Contract Type

agreement

EmeryvilleManufacturingBiotechnologyHealthcareHealth CareFashionBeautyPublic SafetyCosmetics

Description

NovaBay Pharmaceuticals has entered into a definitive asset purchase agreement with PRN Physician Recommended Nutriceuticals to sell the Avenova brand and business for $9.5 million in cash. The transaction is expected to close in the fourth quarter of 2024.

Company Information

Company

Novabay

Location

Emeryville, California, United States

About

Novabay is one of the largest premium sodium bicarbonate producers in the Asia-Pacific region, excluding China. It supplies high-value grades for pharmaceutical, personal care, and food applications. The company is certified with key cGMP and API standards and operates a fully automated facility. Novabay has a current production capacity of approximately 60,000 tonnes.

Related People

Suggested for you

Choose your plan to reveal verified contacts

Choose your plan to reveal verified contacts

Predictive Intelligence
Strategic

ML-powered predictions for Novabay's next move

Learn about Strategic plan

Agreement Insights

Based on industry data
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.